Product Information

TOPAMAX 25 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $6.5761 per EA under NDC 50458063965. Its NADAC has been published 643 times since Nov 28, 2013.

FDA first approved this application on Dec 24, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPAMAX 25 MG TABLET

topiramate
$6.5761per EA

Strength

25 mg/1

NDC

50458063965

Classification

Brand

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA020505

FDA Approved

12/24/1996

TE Code

AB

On Market Since

1/1/1997

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPAMAX 25 MG TABLET has been published 643 times since Nov 28, 2013, and over the history we have for it it has risen 86.9%. The table below summarizes its recorded NADAC range and movement.

Current price$6.5761 per EA
All-time high$6.5898 (Jun 10, 2026)
All-time low$3.5185 (Nov 28, 2013)
52-week high$6.5898
52-week low$6.3793
Median price$5.8342
Average price$5.5121
Largest weekly change+9.9% (Jan 14, 2015)
Weeks tracked643
Tracking sinceNov 28, 2013

Price History

1W

-0.1%

1M

-0.1%

3M

-0.2%

6M

+0.1%

1Y

+3.0%

3Y

+5.5%

5Y

+8.9%

All

+86.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPAMAX 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPAMAX 25 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $6.5761 per EA (NDC 50458063965), effective Aug 19, 2026.

How has the price of TOPAMAX 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPAMAX 25 MG TABLET has risen 86.9%. It has been tracked across 643 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOPAMAX 25 MG TABLET?

Since Nov 28, 2013, the NADAC for TOPAMAX 25 MG TABLET has ranged from a low of $3.5185 (Nov 28, 2013) to a high of $6.5898 (Jun 10, 2026), with a median of $5.8342 per EA.

Are there cheaper alternatives to TOPAMAX 25 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 25 MG TABLET, is $0.0256 per EA — about 99% below TOPAMAX 25 MG TABLET.

Who manufactures TOPAMAX 25 MG TABLET?

TOPAMAX 25 MG TABLET (NDC 50458063965) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.